HomeCompareZRSEF vs MRK

ZRSEF vs MRK: Dividend Comparison 2026

ZRSEF yields 19.54% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ZRSEF wins by $14.2K in total portfolio value
10 years
ZRSEF
ZRSEF
● Live price
19.54%
Share price
$10.24
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$71.0K
Annual income
$6,413.37
Full ZRSEF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — ZRSEF vs MRK

📍 ZRSEF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodZRSEFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ZRSEF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ZRSEF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ZRSEF
Annual income on $10K today (after 15% tax)
$1,660.81/yr
After 10yr DRIP, annual income (after tax)
$5,451.36/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $2,877.05/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ZRSEF + MRK for your $10,000?

ZRSEF: 50%MRK: 50%
100% MRK50/50100% ZRSEF
Portfolio after 10yr
$63.9K
Annual income
$8,105.76/yr
Blended yield
12.69%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

ZRSEF
Analyst Ratings
3
Hold
1
Sell
Consensus: Hold
Altman Z
1.5
Piotroski
3/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ZRSEF buys
0
MRK buys
0
No recent congressional trades found for ZRSEF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricZRSEFMRK
Forward yield19.54%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$71.0K$56.8K
Annual income after 10y$6,413.37$9,798.13
Total dividends collected$39.9K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: ZRSEF vs MRK ($10,000, DRIP)

YearZRSEF PortfolioZRSEF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$12,654$1,953.89$11,206$366.19+$1.4KZRSEF
2$15,850$2,310.68$12,650$502.35+$3.2KZRSEF
3$19,665$2,705.02$14,407$694.19+$5.3KZRSEF
4$24,178$3,136.46$16,585$967.82+$7.6KZRSEF
5$29,474$3,603.99$19,342$1,363.89+$10.1KZRSEF
6$35,644$4,106.05$22,913$1,947.19+$12.7KZRSEF
7$42,779$4,640.65$27,662$2,823.89+$15.1KZRSEF
8$50,979$5,205.31$34,159$4,173.35+$16.8KZRSEF
9$60,345$5,797.25$43,337$6,308.80+$17.0KZRSEF
10$70,982$6,413.37$56,776$9,798.13+$14.2KZRSEF

ZRSEF vs MRK: Complete Analysis 2026

ZRSEFStock

DocMorris AG operates e-commerce pharmacies and a wholesale business for medical and pharmaceutical products in Switzerland and internationally. The company offers consumer health, beauty, and personal care products, as well as medicines management services. It also operates stationary pharmacy shops. The company sells its products directly to physicians, online mail-order pharmacies, and private individuals under the Zur Rose, PromoFarma, TeleClinic, and DocMorris brands. The company was formerly known as Zur Rose AG and changed its name to Zur Rose Group AG in May 2015. The company was founded in 1993 and is headquartered in Frauenfeld, Switzerland.

Full ZRSEF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this ZRSEF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ZRSEF vs SCHDZRSEF vs JEPIZRSEF vs OZRSEF vs KOZRSEF vs MAINZRSEF vs JNJZRSEF vs ABBVZRSEF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.